Compare AURA & ELVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AURA | ELVA |
|---|---|---|
| Founded | 2007 | 1996 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 357.5M | 359.5M |
| IPO Year | 2021 | N/A |
| Metric | AURA | ELVA |
|---|---|---|
| Price | $5.70 | $7.64 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 3 |
| Target Price | ★ $20.20 | $9.67 |
| AVG Volume (30 Days) | 188.2K | ★ 830.2K |
| Earning Date | 03-23-2026 | 02-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.10 |
| Revenue | N/A | ★ $68,211,000.00 |
| Revenue This Year | N/A | $40.20 |
| Revenue Next Year | N/A | $49.84 |
| P/E Ratio | ★ N/A | $78.90 |
| Revenue Growth | N/A | ★ 56.11 |
| 52 Week Low | $4.35 | $1.80 |
| 52 Week High | $8.16 | $11.88 |
| Indicator | AURA | ELVA |
|---|---|---|
| Relative Strength Index (RSI) | 49.76 | 38.87 |
| Support Level | $5.26 | $8.11 |
| Resistance Level | $5.82 | $9.50 |
| Average True Range (ATR) | 0.32 | 0.97 |
| MACD | 0.00 | -0.37 |
| Stochastic Oscillator | 34.83 | 10.61 |
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.
Electrovaya Inc is a technology-focused lithium-ion battery company engaged in designing, developing and manufacturing battery cells, modules and systems based on its proprietary Infinity Battery Technology, which provides high safety performance, long cycle life and durability. The Company supplies low-voltage and high-voltage battery systems for industrial and transportation markets, including material-handling equipment, robotic vehicles, electric buses and trucks, and energy-storage installations, and its products are suitable for mission-critical applications. it maintains an expanding intellectual-property portfolio, develops next-generation solid-state and hybrid solid-state battery technologies, and sells its products through OEM relationships, dealer networks and direct sales.